Entry into force of the EU Clinical Trials Information System: a missed opportunity

The Medical Nutrition International Industry (MNI) regrets that the EU Clinical Trials Information System (CTIS) does not include a mandatory assessment of the nutritional status of the patient during and after the trials.
As this piece of legislation comes into force, MNI would like to highlight the importance of aiming at an optimal nutritional status of the patient as part of patient’s protection and care during the trial and to allow for the best health outcome at every stage of research.

There is unequal access to home parenteral nutrition in Europe – MNI White Paper

Despite the proven benefits of home parenteral nutrition (HPN), the extent to which it is used across Europe varies markedly. Reasons for this include:
– The absence of legislative frameworks to support the provision of HPN
– Inconsistent enforcement of legislation when such a framework does exist
– Mixed acceptance and implementation of HPN clinical guidelines
– A lack of reimbursement for the intervention

What is a Food for Special Medical Purposes? and how to recognise it?

It is not always easy to understand the differences among various categories of food products and under which law they are regulated. MNI has developed a statement of principles intended to provide information on Foods for Special Medical Purposes (FSMPs) vs General / Fortified Food in the context of the European Union regulatory framework.

Experts urge immediate action to make nutritional care mandatory in cancer care

On 13 September at the Joint Policy Seminar at ESPEN Congress, renowned European experts from ESPEN, ECPC, ECO and EFAD stressed the vital importance of nutrition for treatment and quality of life of patients with cancer. They called upon stakeholders to join forces to implement optimal nutritional care for all cancer patients and throughout their cancer journey, launching 7 actionable recommendations.

“Delivering optimal nutritional care for all throughout the cancer journey: what will it take?”

Joint Policy Seminar – Monday, 13 September 2021 – 11:45-13:00 CET
With over 2.7million new cancer cases diagnosed each year in Europe, how can we ensure access to early nutritional care for all, rather than the lucky few?
Malnutrition remains the single most common complication in cancer, yet many gaps and barriers remain that cause patients to suffer avoidable complications and poorer than anticipated outcomes.
ESPEN has already produced practical clinical guidelines on how to deliver nutritional care, but what more is needed to make it happen in practice?

Video “From Hospital to Home with Parenteral Nutrition” now available in Polish

People of all ages can be prescribed parenteral nutrition because of varying diseases. Home Parenteral Nutrition (HPN) may improve patients’ quality of life by supporting them in their daily activities. Patients with chronic conditions and who need nutritional support can receive parenteral nutrition at home without the need to travel to the hospital.